ArticleCureus2025
Clinical Presentation and Management of Acute Exacerbation of Asthma During Pregnancy at a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Asthma is a chronic airway disorder posing significant risks during pregnancy. Acute exacerbations compromise maternal oxygenation and increase adverse perinatal outcomes, yet data from low- and middle-income countries are limited. Objective The objective of this study was to evaluate the clinical presentation, management strategies, and maternal-fetal outcomes of acute asthma exacerbations during pregnancy in a tertiary care hospital, and to highlight differences from patterns reported in high-income settings. Methodology This descriptive observational study was conducted at Ayub Teaching Hospital, Abbottabad, Pakistan, from March 2021 to March 2022. A total of 106 pregnant women with acute exacerbation were included. Clinical assessment covered symptoms, peak expiratory flow rate (PEFR), oxygen saturation, and parity. Management followed hospital protocols with short-acting beta-agonists (SABA), systemic corticosteroids, oxygen supplementation, and, when required, intravenous magnesium sulfate or mechanical ventilation. Maternal and fetal outcomes were recorded. Data were analyzed using IBM SPSS Statistics for Windows, version 25 (IBM Corp., Armonk, New York, United States); chi-square and Kruskal-Wallis tests assessed variables, and multivariate logistic regression identified predictors (p<0.05). Results Mild and moderate exacerbations accounted for 42 (39.6%) and 46 (43.4%) cases, while 18 (17.0%) were severe. Primigravida women comprised 42.5% (n=45) of the cohort. PEFR and oxygen saturation declined with severity (p<0.001). All patients received SABA; corticosteroids and oxygen were more common in moderate and severe cases. IV magnesium sulfate (n=11/18, 61.1%) and mechanical ventilation (n=4/18, 22.2%) were mainly required in severe cases. Maternal complications, including hypoxemia (n=9/18, 50.0%) and ICU admission (n=12/18, 66.7%), rose with severity (p<0.001). Fetal complications were higher in severe cases, but were not statistically significant. Conclusion Acute asthma exacerbations in pregnancy are mainly mild to moderate. Severe cases carry substantial maternal risk, underscoring early recognition, guideline-based management, and multidisciplinary care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.